3rd International One Health Congress in Amsterdam

Closer collaboration between human and animal Health


  • Infectious diseases that can be passed between animals and people, such as influenza, rabies, Ebola virus and West Nile virus
  • Diseases that are common to animals and people, such as  arthritis, cancer, diabetes and allergies


Amsterdam, The Netherlands (March 16, 2015) – A panel of experts in both human and animal healthcare called for greater collaboration in combating the increasing threat of animal-transmitted infectious diseases and to more effectively innovate under the umbrella of One Health to prevent and treat chronic diseases that are common to animals and people. This call to action came at a satellite symposium held today at the 3rd International One Health Congress in Amsterdam*. The event was sponsored by the animal health company Zoetis.



People and Animals are More Closely Linked than Ever Before


Ever expanding suburban development means more people are encroaching on dwindling natural reserves, bringing people and livestock in ever closer contact with wild animals. At the same time, more and more urban dwellers are adopting companion animals, and these pets are more integrated into family life, and live in closer contact with their human masters. People and animals are more closely linked than ever before.  Therefore, zoonotic diseases, those transmitted between animals and humans, represent a very real concern, and not only in the developing world. [1]


Animal-transmitted infectious diseases will continue to be a major health challenge in the future. More than 60 percent of all infectious diseases that plague mankind are of wild animal origin and 75 percent of emerging human diseases are zoonotic. [1,3]  Zoonotic diseases are likely to increase in prevalence as a result not only of the increasingly close association with animals, but also increased global travel, and the ongoing trade in exotic animals, to mention just a few examples. [1]  As effective preventative measures are beyond the abilities of any one healthcare organisation, a diverse collection of private and public organisations, researchers, physicians and veterinarians are increasingly collaborating under the umbrella of One Health to protect both human and animal health, as well as to ensure the supply of safe and affordable food. [1]


 “Animal health is also about human health and the linkage between the two is fundamental, whether we are talking about zoonotic diseases that can be passed between animals and people or chronic disease that affect people and animals alike,” said Anton Pijpers, professor of Veterinary Medicine at the University of Utrecht.


Alejandro Bernal, Executive Vice President and Area President, Europe, Africa and Middle East at Zoetis and Chairman of IFAH-Europe*, the organisation representing manufacturers of veterinary medicines, vaccines and other animal health products in Europe, explained: “Detecting and controlling disease in animals should not only occur after human cases, which is too often the case, it should start when outbreaks of zoonotic diseases are first seen in animals. Therefore, an integrated human-animal approach rather than the classical, separated approach is needed; with the rational use of anti-infectives, vaccines and other control measures in both humans and animals. The current collaboration and business model is not optimal today. There are tools, methodologies and competencies to approach these challenges, but there is a need to invest in sustainable new solutions, and more importantly, to improve cooperation between human and animal health.”



Better Collaboration Now to Face Tomorrow’s Problems


Organisations such as IFAH Europe, EFPIA*, WHO*, FAO* and OIE* need to work together with national governments to capture the direct and indirect impacts of zoonotic diseases – and to publish the associated costs, which would over time lead to more focus on zoonotic disease prevention and control rather than treatment once humans are affected.


Magda Chlebus, director of Science Policy at the European Federation of Pharmaceutical Industries and Associations (EFPIA) stressed that, "Human, animal and environmental health face many common or related challenges. Success in addressing these will, more than ever, rely on our ability to integrate know-how, sciences and technologies from many sectors and companies. The threat of resistant bacteria is a challenge that requires such a collaboration and coordination.” The EFPIA invited animal health companies to jointly address the One Health challenge in the framework of the EU public-private Innovative Medicines Initiative.


Affirming its commitment to One Health collaborations, Michelle Haven, a veterinarian and senior vice president of Corporate Development, Alliances and Solutions at Zoetis said, “We are enthusiastic about the idea of fostering closer collaboration between human and animal health. We firmly believe it could lead to the faster development of sophisticated health tools and technologies that will not only better protect against infectious diseases, but also help tackle some of the major chronic disease challenges of the 21st century, such as cardiovascular disease and osteoarthritis. A One Health approach may also provide added value to new biotech and start-up companies that could potentially commercialise their inventions earlier in the veterinary market.”


Haven called out two examples in which taking a One Health approach to control zoonotic disease have met with success. Multidisciplinary groups have coalesced under the banner of One Health with the aim of eradicating rabies in both dogs and humans before 2030.  She also noted a collaboration between Zoetis, the Commonwealth Scientific and Industrial Research Organisation in Australia and the Henry M. Jackson Foundation to develop a vaccine to control the Hendra virus, a zoonotic disease that can be life-threatening to horses and people and has an economic impact. As Professor Adrian Hill, head of the Jenner Institute, Oxford University explained: “Often the shutting down and quarantining of areas due to a disease outbreak is a more significant loss than the actual infection or animal destruction. Media reactions and economic slowdown are much more impactful than the disease itself. That was what happened with the Hendra virus outbreaks in Australia.”



One Health Collaboration to Prevent Chronic Diseases


The One Health collaborative approach goes beyond animal-borne diseases infecting humans; it also includes ‘translational’ medicine. This is where knowledge in certain areas is applied to others. For example, many similar diseases occur in both animals and humans: osteoarthritis, kidney disease, cardiovascular disease and a variety of cancers, to name just a few. In these cases, knowledge accumulated in one area of research can be translated into solutions in other species. [9]  Practical examples of this include the sharing of compound libraries between animal and human health researchers, and the development of new in vivo models at the preclinical research stage that accelerate the development of new medicines. There are financial benefits as well, with products finding new uses and new markets in different species. Zoetis is active in the area of translational medicine, providing expertise in veterinary biopharmaceuticals (monoclonal antibodies and other therapeutic proteins) for the evaluation of targets beyond rodent species.


There is a growing priority that human and animal health organisations should strengthen their links to be ready to tackle tomorrow’s problems. As a concrete contribution to the One Health initiative, Zoetis is organising expert roundtable discussions with representatives from health bodies in both human and animal health. These discussions will take place on March 17, 2015 and will focus on ways to improve collaboration at both the human and animal health levels.



For more information about the 3rd International One Health conference, visit http://www.iohc2015.com/



About Zoetis


Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2014, the company generated annual revenue of $4.8 billion. With approximately 10,000 employees worldwide at the beginning of 2015, Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in 120 countries.


For more information, visit www.zoetis.com





  • * IOHC Satellite Symposium – Monday 16th March 2015

    Similar diseases – Similar solutions: A Call for a Closer Collaboration between Animal and Human Health

    1. Mr Alejandro Bernal – Chairman of the International Federation of Animal Health (IFAH) Europe– IFAH Europe’s perspective on “One Health” – Belgium
    2. Mrs Magda Chlebus – Director of Science Policy of the European Federation of Pharmaceutical Industries and Associations (EFPIA) – EFPIA’s interests in “One Health” and opportunities through the Innovative Medicine Initiative (IMI) – Belgium
    3. Prof. Anton Pijpers – Vice President of the Executive Board of Utrecht University – The interlink between healthy people and animal health – Netherlands
    4.Prof. Adrian Hill – Head of the Jenner Institute, Oxford University – “Rapid responses to new epidemics” – UK
    5. Dr Emmanuel Hanon – Senior Vice President, Head of Vaccine Discovery & Development at GSK – The need for “One Health” innovation and alliances in human health – Belgium
    6. Dr Michelle Haven – Senior Vice President, Head of Corporate Development, Alliances and Solutions at Zoetis – The need for “One Health” innovation and alliances in animal health – USA




  1. Kahn LH, Kaplan B, Steele JH (2007) Confronting zoonoses through closer collaboration between medicine and veterinary medicine (as ‚one medicine‘). Vet Ital 43: 5-19.
  2. Bidaisee S, Macpherson CN (2014) Zoonoses and one health: a review of the literature. J Parasitol Res 2014: 874345.
  3. (2011) French position on the One Health concept. Paris: French Ministry of European and Foreign Affairs.
  4. (2014) Rabies: Fact Sheet #99. Geneva: World Health Organization. http://www.who.int/mediacentre/factsheets/fs099/en/ – Last accessed February 2015.
  5. Fooks AR, Banyard AC, Horton DL, Johnson N, McElhinney LM, et al. (2014) Current status of rabies and prospects for elimination. Lancet 384: 1389-1399.
  6. Global Alert and Response (GAR): Hendra Virus (HeV) Infection. World Health Organization. http://www.who.int/csr/disease/hendra/en/ – Last accessed February 2015.
  7. Middleton D (2014) Hendra virus. Vet Clin North Am Equine Pract 30: 579-589.
  8. Eisler MC, Lee MR, Tarlton JF, Martin GB, Beddington J, et al. (2014) Agriculture: Steps to sustainable livestock. Nature 507: 32-34.
  9. Lerner H, Berg C. (2015) The concept of health in One Health and some practical implications for research and education: what is One Health? Infect Ecol Epidemiol. 2015:25300.




  • CSIRO: Commonwealth Scientific and Industrial Research Organisation
  • EFPIA: European Federation of Pharmaceutical Industries and Associations
  • FAO: Food and Agriculture Organization of the United Nations
  • IFAH Europe: International Federation of Animal Health
  • OIE: World Organization for Animal Health
  • WHO: World Health Organization


Zoetis, 16.03.2015 (tB).


Fitness watches generate useful information, but increase patient anxiety
A new device provides added protection against COVID-19 during endoscopic…
81 million Americans lacking space or bathrooms to follow COVID…
Front-line physicians stressed and anxious at work and home
EULAR: High-Dose Glucocorticoids and IL-6 Receptor inhibition can reduce COVID-19…


Wie ein Schmerz den anderen unterdrückt
Opioidtherapien im palliativen Praxisalltag: Retardierte Analgetika zeigen Vorteile
Krankenhäuser und Praxen müssen sich bei der Schmerztherapie nach Operationen…
Morbus Fabry mittels Datenanalysen aus dem PraxisRegister Schmerz aufspüren
Neandertaler besaßen niedrigere Schmerzschwelle


Suliqua®: Eine sinnvolle Option, wenn die BOT zur Blutzuckerkontrolle nicht…
„Körperstolz“: Michael Krauser managt seinen Diabetes digital
Der richtige Sensor – von Anfang an
Diabetes mellitus: Ein Risikofaktor für frühe Darmkrebserkrankungen
Fastenmonat Ramadan: Alte und neue Herausforderung für chronisch Erkrankte während…


Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…
Fast Food, Bio-Lebensmittel, Energydrinks: neue Daten zum Ernährungsverhalten in Deutschland
Neue Daten zur Ernährungssituation in deutschen Krankenhäusern und Pflegeheimen: Mangelernährung…
Baxter: Parenterale Ernährung von Patienten mit hohem Aminosäurenbedarf


Bestmögliche Versorgungssicherheit bei der Krebstherapie mit CAR-T-Zellen
Darolutamid bei Prostatakarzinom: Hinweis auf beträchtlichen Zusatznutzen
Multiples Myelom: Wissenschaftler überprüfen den Stellenwert der Blutstammzelltransplantation
Neues zur onkologischen Supportiv- und Misteltherapie und aktuelle Kongress-Highlights zum…
Neue Darreichungsform zur Antiemese bei Chemotherapie: Akynzeo® ist ab sofort…


Multiple Sklerose: Novartis’ Siponimod verzögert Krankheitsprogression und Hirnatrophie bei aktiver…
Neurofilamente als Diagnose- und Prognosemarker für Multiple Sklerose
Bedeutung der Langzeittherapie bei Multipler Sklerose – mehr Sicherheit und…
Bristol Myers Squibb erhält Zulassung der Europäischen Kommission für Ozanimod…
Einige MS-Medikamente könnten vor SARS-CoV-2/COVID-19 schützen


Neue Studie zur tiefen Hirnstimulation bei Parkinson-Erkrankung als Meilenstein der…
Putzfimmel im Gehirn
Parkinson-Patienten in der Coronakrise: Versorgungssituation und ein neuer Ratgeber
Neuer Test: Frühzeitige Differenzialdiagose der Parkinson-Erkrankung
Gegen das Zittern: Parkinson- und essentiellen Tremor mit Ultraschall behandeln…